LACTYFERRIN ™ Forte and ZINC Defense™ and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Patients With COVID-19

Condition:   COVID-19 Interventions:   Drug: Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™;   Drug: Placebo Sponsors:   Jose David Suarez, MD;   Sesderma S.L.;   Westchester General Hospital Inc. DBA Keralty Hospital Miami;   MGM Technology Corp Not yet recruiting

Source: ClinicalTrials.gov - March 24, 2023 Category: Research Source Type: clinical trials